Inhibitors of thrombocytic function for prophylaxis of coronary heart disease
Loew, D.; Breddin, K.; Uberla, K.
Münchener Medizinische Wochenschrift 124(1): 46-56
1982
ISSN/ISBN: 0341-3098 PMID: 6120454 Document Number: 183487
Document emailed within 1 workday
Related Documents
Coleman, C.I.; White, C.M. 2007: A comparison of different protease inhibitors on coronary heart disease risk Connecticut Medicine 71(1): 15-17Hamilton, V.H.; Racicot, F.E.; Zowall, H.; Coupal, L.; Grover, S.A. 1995: The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease. Estimating the benefits of increasing HDL-C JAMA 273(13): 1032-1038
Nikiforova, T.I.; Kniazeva, T.A. 2012: Artificial silicious-carbon dioxide baths for the rehabilitation and secondary prophylaxis in the patients presenting with arterial hypertension associated with coronary heart disease Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 5: 11-15
Petrova, O.V.; Shashin, S.A.; Tarasov, D.G. 2014: The importance of thrombocytic indices in patients operated for chronic rheumatic heart disease Klinicheskaia Meditsina 92(8): 20-26
Karsch, K.R.; Bornikoel, K.; Kreuzer, H.; Neuhaus, K.L. 1974: Myocardial function of the right ventricle in coronary heart disease Zeitschrift für Kardiologie 1974(Suppl 1): 15
Aronov, D.M.; Krasnitskiĭ, V.B.; Bubnova, M.G.; Posdniakov, I.M.; Ioseliani, D.V.; Shchegol'kov, A.N.; Efremushkin, G.G.; Osipova, I.V.; Guliaeva, S.F.; Mal'chikova, S.V.; Kazakevich, E.V.; Liamina, N.P.; Riamzina, I.N.; Mingazetdinova, L.N. 2006: Exercise in outpatient complex rehabilitation and secondary prophylaxis in patients with ischemic heart disease after acute coronary events (a cooperative trial in Russia) Terapevticheskii Arkhiv 78(9): 33-38
Gorbunov, V.V.; Tsarenok, S.I.; Rosin, I.V. 2008: Lymphocytic-thrombocytic adhesion and production of blood serum cytokines in rheumatic heart disease Terapevticheskii Arkhiv 80(12): 37-39
Heinzl, S. 1991: Coronary heart disease and disorders of left ventricular function Medizinische Monatsschrift für Pharmazeuten 14(12): 367-369
Martens, L.L.; Guibert, R. 1994: Cost-effectiveness analysis of lipid-modifying therapy in Canada: comparison of HMG-CoA reductase inhibitors in the primary prevention of coronary heart disease Clinical Therapeutics 16(6): 1052-62; discussion 1036
Rousseau, M.F.; Wyns, W.; Detry, J.M.; Bertrand, M.E.; Pouleur, H. 1980: Interest of indices of left ventricular function in assessment of coronary heart disease Annales de Cardiologie et D'angeiologie 29(4): 339-346
Hamsten, A.; Karpe, F.; Båvenholm, P.; Silveira, A. 1994: Interactions amongst insulin, lipoproteins and haemostatic function relevant to coronary heart disease Journal of Internal Medicine. Supplement 736: 75-88
Brandt, D.; Fluch, N.; Tschech, G.; Sterz, F.; Klein, W. 1986: Pharmacologic modification of diastolic ventricular function in patients with coronary heart disease Wiener Medizinische Wochenschrift 136(21-22): 545-549
Nepomniashchikh, V.A.; Lomivorotov, V.V.; Deriagin, M.N.; Kniaz'kova, L.G.; Mogutnova, T.A.; Lomivorotov, V.N. 2007: Oxidative stress and hepatic monooxygenase function in patients with coronary heart disease before and after cardiac surgery Anesteziologiia i Reanimatologiia 2007(5): 46-51
Azovtsev, R.A. 1988: The contractile function of the myocardium in patients with ischemic heart disease after the mammary-coronary artery shunting Vestnik Khirurgii Imeni I. I. Grekova 140(2): 6-10
Kuimov, A.D.; Maianskaia, S.D.; Luksha, E.B.; Volkova, I.I.; Barbarich, V.B.; Shliakhov, S.O.; Iakovlev, A.V.; Poliakova, A.M. 1999: Trimetazidine effects on exercise tolerance and left ventricular diastolic function in patients with coronary heart disease Terapevticheskii Arkhiv 71(1): 39-42
Pech, H.J.; Parsi, R.A. 1986: Effect of slow-release ISDN on cardiac function in patients with coronary heart disease during bicycle ergometry Cor et Vasa 28(4): 257-265
Repinskaia, N.P.; Demidova, A.V. 1992: Effect of the tourniquet test on fibrinolysis, thrombocytic hemostasis and the antithrombin IIi system in ischemic heart disease and exercise-induced stenocardia of the III-IV functional classes Kardiologiia 32(3): 19-21
Thormann, J.; Schlepper, M.; Kramer, W.; Gottwik, M. 1982: Mechanism and effects of the cardiotonic AR-L 115 BS in coronary heart disease: improved ventricular function and regional wall motility without angina pectoris Zeitschrift für Kardiologie 71(11): 736-746
Liu, H.; Chen, Z.; Gao, R. 1995: Effects of low dose aspirin on platelet function and prostaglandins metabolism in systemic and coronary circulation in patients with ischemia heart disease Zhonghua Nei Ke Za Zhi 34(9): 595-598
Zhang, J.; Tan, H.; Shi, X-ning.; Zheng, X-wei.; Li, Y-mei.; Li, S-fen.; Ma, Z-yun. 2006: The effect of nasal continuous positive airway pressure on endothelial function in obstructive sleep apnea-hypopnea syndrome with coronary heart disease Zhonghua Nei Ke Za Zhi 45(3): 188-191